People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.
PRESTIGIO RING: “An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification” / Mazzitelli, M.; Zazzi, M.; Marchetti, G.; Spagnuolo, V.; Santoro, M. M.; Focà, E.; Cattelan, A.; Castagna, A.; Mazzitelli, M.; Zazzi, M.; Marchetti, G.; Spagnuolo, V.; Santoro, M. M.; Focà, E.; Cattelan, A.; Castagna, A.. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 46:4(2023), pp. 407-411.
PRESTIGIO RING: “An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification”
Spagnuolo V.;Castagna A.;Spagnuolo V.;Castagna A.Ultimo
2023-01-01
Abstract
People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
